Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging
Sepideh Saadatmand(Erasmus MC), Harry J. de Koning(Erasmus MC), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Eveline A.M. Heijnsdijk(Erasmus MC), Claudette E. Loo(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Inge-Marie Obdeijn, Jan C. Oosterwijk(University Medical Center Groningen), Madeleine M.A. Tilanus‐Linthorst(Erasmus University Rotterdam), Maartje J. Hooning(Erasmus MC Cancer Institute), Emiel J. Rutgers(Oncode Institute)
Cited by 65
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k